Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-22 08:03 CEST (UTC+2h)

Outlier in BE [Study As­sess­ment]

posted by ramgopi - India, 2018-03-14 11:29  - Posting: # 18533
Views: 1,426

Dear All,


We have discussed enough regarding discordant outliers in BE study in the past, but we have struct with typical situation and i would like to know experts opinion on this regard.

we have a done a BE study for GCC submission with two way crossover, here one subject shows less concentration in reference product and the T/R ratio for Cmax 2.43 and AUCt 2.35, because of this subject the study failed in border, if we excluded this as a outlier the 90% CI is within the acceptance limit.

90% CI before excluding particular subject

Dependent   Ratio_  %RefCI_90_Lower  CI_90_Upper    CV%
Ln(Cmax)    115.46      106.23         125.49      19.47%
Ln(AUClast) 110.25      102.66         118.40      16.64%

90% CI After excluding particular subject

Dependent   Ratio_  %RefCI_90_Lower  CI_90_Upper    CV%
Ln(Cmax)    112.14      104.48         120.36      16.12%
Ln(AUClast) 107.34      101.29         113.75      13.27

It is evident that something happen for this subject during clinical phase but the CRO failed to notify the incident.

GCC just following EMA guidance so as per EMA this is failed study, but out of my curiosity Is there any way to scientifically justify and exclude this subject from statistical calculation.

please let me know your opinion

thanks & Regards;-)


Edit: Category changed; see also this post #1. Tabulators changed to spaces and BBcoded; see also this post #6[Helmut]

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,413 posts in 3,912 threads, 1,175 registered users;
online 37 (0 registered, 37 guests [including 26 identified bots]).

The greatest shortcoming of the human race is our inability
to understand the exponential function.    Albert Bartlett

BEBAC Ing. Helmut Schütz